These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27538645)

  • 1. Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis.
    Ahmed SS; Husain RS; Kumar S; Ramakrishnan V
    J Neurol Sci; 2016 Sep; 368():255-62. PubMed ID: 27538645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.
    Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    Drug Metab Pharmacokinet; 2013; 28(2):138-43. PubMed ID: 22971641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MDR1 gene C3435T polymorphism with childhood intractable epilepsy: a meta-analysis.
    Sun G; Sun X; Guan L
    J Neural Transm (Vienna); 2014 Jul; 121(7):717-24. PubMed ID: 24553780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease: A meta-analysis.
    Huang H; Peng C; Liu Y; Liu X; Chen Q; Huang Z
    Medicine (Baltimore); 2016 Oct; 95(40):e4982. PubMed ID: 27749554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis.
    Zu B; Li Y; Wang X; He D; Huang Z; Feng W
    Pharmacogenomics; 2014 Apr; 15(5):667-77. PubMed ID: 24798723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between MDR1 C3435T polymorphism and colorectal cancer risk: A meta-analysis.
    Jin SS; Song WJ
    Medicine (Baltimore); 2017 Dec; 96(51):e9428. PubMed ID: 29390571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Cai M; Liu Z; Li W; Wang Y; Xie A
    Neurosci Lett; 2018 Feb; 665():110-116. PubMed ID: 29191693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson's disease.
    Zhu ZG; Ai QL; Wang WM; Xiao ZC
    Gene; 2013 Nov; 531(1):78-83. PubMed ID: 23916622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: a systematic review and meta-analysis.
    Cheng JW; Zhang LJ; Hou YQ; Zhao Q; Zhang XJ; Chen XF; Bai Y
    Epilepsy Behav; 2014 Jul; 36():173-9. PubMed ID: 24953225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRA rs3129882 A/G polymorphism was not a risk factor for Parkinson's disease in Chinese-based populations: a meta-analysis.
    Ma ZG; Liu TW; Bo YL
    Int J Neurosci; 2015 Apr; 125(4):241-6. PubMed ID: 24849299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of MDR1 gene C3435T polymorphism in predicting childhood refractory epilepsy.
    Lv RJ; Shao XQ; Cui T; Wang Q
    Epilepsy Res; 2017 May; 132():21-28. PubMed ID: 28284049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated analysis with 45,078 subjects confirms the association between SNCA rs11931074 and Parkinson's disease.
    Liu X; Zhu R; Xiao T; Li Q; Zhu Y; He Z
    Neurol Sci; 2018 Dec; 39(12):2061-2069. PubMed ID: 30120622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.
    Yin G; Xiao Z; Ni Y; Qu X; Wu H; Lu H; Qian S; Chen L; Li J; Qiu H; Miao K
    Tumour Biol; 2016 Jul; 37(7):9549-54. PubMed ID: 26790444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies.
    Chen G; Quan S; Hu Q; Wang L; Xia X; Wu J
    Mol Biol Rep; 2012 May; 39(5):5161-8. PubMed ID: 22160574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of
    Sohail A; Arshad A; Tariq T; Bibi A; Aslam S; Irfan M
    Am J Mens Health; 2023; 17(2):15579883231166645. PubMed ID: 37081725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies.
    Li H; Wang B; Chang C; Wu M; Xu Y; Jiang Y
    PLoS One; 2015; 10(3):e0122043. PubMed ID: 25816099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies.
    Wang J; Wang B; Bi J; Li K; Di J
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):979-89. PubMed ID: 22358302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson's disease: a meta-analysis.
    Wang S; Xu YF; Ding XY; Liu ZR; Ding Y; Jin B; Wang S; Ding MP
    Neurosci Lett; 2015 Jul; 599():120-4. PubMed ID: 25986899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor polymorphisms and the susceptibility of Parkinson's disease.
    Wang X; Shen N; Lu Y; Tan K
    Neurosci Lett; 2019 Apr; 699():206-211. PubMed ID: 30763651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the rs1611115 polymorphism in DBH gene with Parkinson's disease: a meta-analysis.
    Kang S; Bi M; Du X; Jiao Q; Jiang H
    Neurol Sci; 2018 Dec; 39(12):2085-2089. PubMed ID: 30187307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.